FDA — authorised 6 April 2012
- Application: NDA202008
- Marketing authorisation holder: AVID RADIOPHARMS INC
- Local brand name: AMYVID
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Amyvid in United States
FDA authorised Amyvid on 6 April 2012
Marketing authorisations
FDA
- Marketing authorisation holder: AVID RADIOPHARMS INC
- Status: approved
Amyvid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Amyvid approved in United States?
Yes. FDA authorised it on 6 April 2012; FDA has authorised it.
Who is the marketing authorisation holder for Amyvid in United States?
AVID RADIOPHARMS INC holds the US marketing authorisation.